Tiburio Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Out of Business

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Out of Business

Tiburio Therapeutics General Information

Description

Provider of novel treatments designed to treat rare neuroendocrine tumors and rare endocrine diseases. The company's clinical stage compounds aids to treat non-functioning pituitary adenoma using a dopamine-somatostatin chimeric molecule that has the potential to shrink or halt tumor growth, enabling patients to get effective treatment where there is significant patient need.

Contact Information

Website
www.tiburio.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 700 Technology Square
  • 2nd Floor
  • Cambridge, MA 02139
  • United States
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Corporate Office
  • 700 Technology Square
  • 2nd Floor
  • Cambridge, MA 02139
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tiburio Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 27-Apr-2021 Completed Out of Business
1. Early Stage VC (Series A) 03-Jan-2019 Completed Startup
To view Tiburio Therapeutics’s complete valuation and funding history, request access »

Tiburio Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Tiburio Therapeutics’s complete cap table history, request access »

Tiburio Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of novel treatments designed to treat rare neuroendocrine tumors and rare endocrine diseases. The company's cli
Biotechnology
Cambridge, MA
9 As of 2021

South San Francisco, CA
 

Kalamazoo, MI
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tiburio Therapeutics Competitors (77)

One of Tiburio Therapeutics’s 77 competitors is Iconic Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Iconic Therapeutics Formerly VC-backed South San Francisco, CA
Metabolic Solutions Development Company Venture Capital-Backed Kalamazoo, MI
Filana Therapeutics Formerly VC-backed Austin, TX
Astrocyte Pharma Venture Capital-Backed Groton, CT
Lucid Psycheceuticals Corporate Backed or Acquired Toronto, Canada
You’re viewing 5 of 77 competitors. Get the full list »

Tiburio Therapeutics Patents

Tiburio Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202105915-D0 Storage stable somatostatin-dopamine chimeric compounds and salt forms thereof Inactive 04-Oct-2019
GB-2590341-A Storage stable somatostatin-dopamine chimeric compounds and salt forms thereof Inactive 04-Oct-2019
WO-2021067897-A1 Storage stable somatostatin-dopamine chimeric compounds and salt forms thereof Inactive 04-Oct-2019 A61K38/31

Tiburio Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tiburio Therapeutics FAQs

  • When was Tiburio Therapeutics founded?

    Tiburio Therapeutics was founded in 2019.

  • Where is Tiburio Therapeutics headquartered?

    Tiburio Therapeutics is headquartered in Cambridge, MA.

  • What is the size of Tiburio Therapeutics?

    Tiburio Therapeutics has 9 total employees.

  • What industry is Tiburio Therapeutics in?

    Tiburio Therapeutics’s primary industry is Biotechnology.

  • Is Tiburio Therapeutics a private or public company?

    Tiburio Therapeutics is a Private company.

  • What is Tiburio Therapeutics’s current revenue?

    The current revenue for Tiburio Therapeutics is .

  • How much funding has Tiburio Therapeutics raised over time?

    Tiburio Therapeutics has raised $31M.

  • Who are Tiburio Therapeutics’s competitors?

    Iconic Therapeutics, Metabolic Solutions Development Company, Filana Therapeutics, Astrocyte Pharma, and Lucid Psycheceuticals are some of the 77 competitors of Tiburio Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process